This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kovar, H. Articles by Gadner, H. Search for Related Content PubMed PubMed Citation Articles by Kovar, H. Articles by Gadner, H.

The EWS Protein Is Dispensable for Ewing Tumor Growth¹

Children’s Cancer Research Institute, St. Anna Kinderspital, Kinderspitalgasse 6, 1090 Vienna, Austria

EWS encodes a ubiquitously expressed RNA binding protein with largely unknown function. In Ewing sarcoma family tumors (EFT), one allele is rearranged with an ETS gene. This is the first description of an EFT with a complete EWS deficiency in the presence of two copies of a rearranged chromosome 22 carrying an interstitial EWS-FLI1 translocation. Absence of EWS protein suggested that it is dispensable for EFT growth. By sequencing of EWS cDNA from unrelated EFTs, we excluded inactivation of EWS as a general mechanism in EFT pathogenesis. Rather, EWS was found to be uniformly expressed in two splicing variants of similar abundancy, EWS and EWSß, which differ in a single amino acid. Three EWS negative cell lines were established, which will serve as valuable models to study normal and aberrant EWS function upon reintroduction into the tumor cells.

This article has been cited by other articles:

				L. J. Embree, M. Azuma, and D. D. Hickstein Ewing Sarcoma Fusion Protein EWSR1/FLI1 Interacts with EWSR1 Leading to Mitotic Defects in Zebrafish Embryos and Human Cell Lines Cancer Res., May 15, 2009; 69(10): 4363 - 4371. [Abstract] [Full Text] [PDF]

				D. N.T. Aryee, M. Kreppel, R. Bachmaier, A. Uren, K. Muehlbacher, S. Wagner, H. Breiteneder, J. Ban, J. A. Toretsky, and H. Kovar Single-chain Antibodies to the EWS NH2 Terminus Structurally Discriminate between Intact and Chimeric EWS in Ewing's Sarcoma and Interfere with the Transcriptional Activity of EWS In vivo. Cancer Res., October 15, 2006; 66(20): 9862 - 9869. [Abstract] [Full Text] [PDF]

				J. A. Toretsky, V. Erkizan, A. Levenson, O. D. Abaan, J. D. Parvin, T. P. Cripe, A. M. Rice, S. B. Lee, and A. Uren Oncoprotein EWS-FLI1 Activity Is Enhanced by RNA Helicase A Cancer Res., June 1, 2006; 66(11): 5574 - 5581. [Abstract] [Full Text] [PDF]

				R. Pio, I. Zudaire, I. Pino, Z. Castano, N. Zabalegui, S. Vicent, F. Garcia-Amigot, M. D. Odero, M. D. Lozano, J. Garcia-Foncillas, et al. {alpha}CP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant {alpha}CP-4a, Is Underexpressed in Lung Cancer Cancer Res., June 15, 2004; 64(12): 4171 - 4179. [Abstract] [Full Text] [PDF]

				L. Spahn, R. Petermann, C. Siligan, J. A. Schmid, D. N. T. Aryee, and H. Kovar Interaction of the EWS NH2 Terminus with BARD1 Links the Ewing's Sarcoma Gene to a Common Tumor Suppressor Pathway Cancer Res., August 15, 2002; 62(16): 4583 - 4587. [Abstract] [Full Text] [PDF]